Last Updated: November 9, 2026

Details for Patent: 9,486,530

Name: Drug Patent Intelligence for US Patent 9486530
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent 9,486,530 protect, and when does it expire?

Patent 9,486,530 protects GANZYK-RTU and is included in one NDA.

Summary for Patent: 9,486,530

Title:	Ganciclovir compositions and related methods
Abstract:	Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided.
Inventor(s):	Sreerama Murthy Mallipeddi, Jonathan E. Sterling, Phanesh B. Koneru
Assignee:	Exela Pharma Sciences LLC
Application Number:	US14/475,206
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 9,486,530

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Exela Pharma	GANZYK-RTU	ganciclovir	SOLUTION;INTRAVENOUS	209347-001	Feb 17, 2017		DISCN	Yes	No	9,486,530	⤷ Start Trial	Y				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.